Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 335 participants.

Also called NCT03318796

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 335 participants (planned count) (from the registry)
Sponsor
Tryton Medical, Inc. (from the registry)
Registry
  • NCT NCT03318796
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03318796. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-22 (actual); primary completion 2019-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent
Acronym
PAS
Intervention (Device)
Coronary Artery Stenting
Lead sponsor
Tryton Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03318796
Content hash
ad1ff5c6fc3799ea76288d25950a0e1d64d1e569b00feda1bf45c9df1b8c56e5